Avanir Pharmaceuticals, Inc.
is a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.

Press Releases

Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical...
Nov 29, 2016
Avanir Pharmaceuticals to Present Data on ONZETRA™ Xsail™ at American Headache Society (AHS) 2016 Annual Scientific Meeting
Jun 9, 2016
NUEDEXTA® Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer’s Disease and other Dementias, Stroke and Traumatic...
Jun 8, 2016
Divider